{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:54:08Z","timestamp":1791165248117,"version":"4.1.0"},"reference-count":35,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2434,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Mutat."],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1002\/humu.20806","type":"journal-article","created":{"date-parts":[[2008,6,20]],"date-time":"2008-06-20T17:36:31Z","timestamp":1213983391000},"page":"22-28","source":"Crossref","is-referenced-by-count":37,"title":["Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping"],"prefix":"10.1155","volume":"30","author":[{"given":"Heidi R.","family":"Madden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve D.","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","reference":[{"key":"10.1002\/humu.20806-BIB1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/oli.2005.15.284","article-title":"Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites","volume":"15","author":"Aartsma-Rus","year":"2005","journal-title":"Oligonucleotides"},{"key":"10.1002\/humu.20806-BIB2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ymthe.2006.02.022","article-title":"Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons","volume":"14","author":"Aartsma-Rus","year":"2006","journal-title":"Mol Ther"},{"key":"10.1002\/humu.20806-BIB3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2199-8-57","article-title":"Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries","volume":"8","author":"Adams","year":"2007","journal-title":"BMC Mol Biol"},{"key":"10.1002\/humu.20806-BIB4","first-page":"54","article-title":"Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies","volume":"49","author":"Beggs","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20806-BIB5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/hmg\/ddg133","article-title":"Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping","volume":"12","author":"Bertoni","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.20806-BIB6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1002\/humu.20806-BIB7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00439-004-1118-6","article-title":"An intragenic deletion\/inversion event in the DMD gene determines a novel exon creation and results in a BMD phenotype","volume":"115","author":"Cagliani","year":"2004","journal-title":"Hum Genet"},{"key":"10.1002\/humu.20806-BIB8","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1093\/nar\/gkg616","article-title":"ESEfinder: a web resource to identify exonic splicing enhancers","volume":"31","author":"Cartegni","year":"2003","journal-title":"Nucleic Acid Res"},{"key":"10.1002\/humu.20806-BIB9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1096\/fj.04-1956rev","article-title":"Molecular, cellular, and pharmacological therapies for Duchenne\/Becker muscular dystrophies","volume":"19","author":"Chakkalakal","year":"2005","journal-title":"FASEB J"},{"key":"10.1002\/humu.20806-BIB10","first-page":"623","article-title":"A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+1.6kbA->G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype","volume":"56","author":"Chillon","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20806-BIB11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/hmg\/7.3.393","article-title":"A G->A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2","volume":"7","author":"De Klein","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.20806-BIB12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/343180a0","article-title":"Very mild muscular dystrophy associated with the deletion of 46% of dystrophin","volume":"343","author":"England","year":"1990","journal-title":"Nature"},{"key":"10.1002\/humu.20806-BIB13","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1126\/science.1104297","article-title":"Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping","volume":"306","author":"Goyenvalle","year":"2004","journal-title":"Science"},{"key":"10.1002\/humu.20806-BIB14","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1212\/WNL.44.12.2388","article-title":"Becker muscular dystrophy with onset after 60 years","volume":"44","author":"Heald","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/humu.20806-BIB15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199410133311503","article-title":"A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations","volume":"331","author":"Highsmith","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.20806-BIB16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1002\/humu.20806-BIB17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(88)90383-2","article-title":"The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein","volume":"53","author":"Koenig","year":"1988","journal-title":"Cell"},{"key":"10.1002\/humu.20806-BIB18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1073\/pnas.98.1.42","article-title":"Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse","volume":"98","author":"Mann","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.20806-BIB19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jgm.295","article-title":"Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy","volume":"4","author":"Mann","year":"2002","journal-title":"J Gene Med"},{"key":"10.1002\/humu.20806-BIB20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/sj.gt.3302800","article-title":"Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD","volume":"13","author":"McClorey","year":"2006","journal-title":"Gene Ther"},{"key":"10.1002\/humu.20806-BIB21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/323266","article-title":"Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity","volume":"69","author":"Metherell","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20806-BIB22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00019052-199710000-00014","article-title":"Functions of dystrophin and dystrophin associated proteins","volume":"10","author":"Michalak","year":"1997","journal-title":"Curr Opin Neurol"},{"key":"10.1002\/humu.20806-BIB23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"10.1002\/humu.20806-BIB24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0968-0004(89)90290-9","article-title":"Dystrophin, the protein product of the Duchenne\/Becker muscular dystrophy gene","volume":"14","author":"Monaco","year":"1989","journal-title":"Trends Biochem Sci"},{"key":"10.1002\/humu.20806-BIB25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: one gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1002\/humu.20806-BIB26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nmd.2005.02.007","article-title":"128th ENMC International Workshop on \u2018Preclinical optimization and Phase I\/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy\u2019 22-24 October 2004, Naarden, The Netherlands","volume":"15","author":"Muntoni","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1002\/humu.20806-BIB27","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1083\/jcb.125.6.1275","article-title":"Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy","volume":"125","author":"Rando","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.20806-BIB28","first-page":"298","article-title":"Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes","volume":"49","author":"Roberts","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20806-BIB29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00019052-199704000-00016","article-title":"Muscular dystrophies and the dystrophin-glycoprotein complex","volume":"10","author":"Straub","year":"1997","journal-title":"Curr Opin Neurol"},{"key":"10.1002\/humu.20806-BIB30","first-page":"686","article-title":"A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human beta-glucuronidase gene","volume":"103","author":"Vervoort","year":"1998","journal-title":"Hum Genet"},{"key":"10.1002\/humu.20806-BIB31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1005753117205","article-title":"A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion","volume":"44","author":"Wang","year":"1997","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/humu.20806-BIB32","first-page":"222","article-title":"Antisense oligonucleotides, exon skipping and the dystrophin gene transcript","volume":"24","author":"Wilton","year":"2005","journal-title":"Acta Myol"},{"key":"10.1002\/humu.20806-BIB33","first-page":"130","article-title":"Modification of pre-mRNA processing: application to dystrophin expression","volume":"8","author":"Wilton","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"10.1002\/humu.20806-BIB34","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.mt.6300095","article-title":"Antisense oligonucleotide induced exon skipping across the human dystrophin gene transcript","volume":"15","author":"Wilton","year":"2007","journal-title":"Mol Ther:"},{"key":"10.1002\/humu.20806-BIB35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1517\/14712598.7.6.831","article-title":"Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy","volume":"7","author":"Yokota","year":"2007","journal-title":"Expert Opin Biol Ther"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.20806","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/humu.20806","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T16:51:56Z","timestamp":1672332716000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.20806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.20806","relation":{},"ISSN":["1059-7794","1098-1004"],"issn-type":[{"value":"1059-7794","type":"print"},{"value":"1098-1004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}